U.S. High Court Lets Reversal Of Avandia Preemption Ruling By 3rd Circuit Stand
WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 5 denied a certiorari petition by GlaxoSmithKline LLC (GSK) to reverse a preemption ruling involving the diabetes drug Avandia based on an...To view the full article, register now.
Already a subscriber? Click here to view full article